Navigation Links
Scotland Announces New Life Science Leadership and Investments at BIO 2010
Date:4/29/2010

CHICAGO, April 29 /PRNewswire/ --  Scotland will showcase the talent and collaborative spirit that has attracted many of the world's leading pharma and biotech companies to its shores at this year's BIO conference, May 3-6 in Chicago.  Heading into the conference, Scottish Enterprise and sector leaders believe Scottish research and the nation's unique integrated industry approach will continue to fuel life sciences growth, particularly in scientific infrastructure, stem cell therapeutics and translational medicine.

"BIO offers Scotland an extraordinary opportunity to demonstrate our cluster's wealth of scientific talent and our ability to innovate R&D across business, academic and government sectors, ultimately providing an energised, strategic location for life science investment and commercialisation," said Rhona Allison, Senior Director Life Sciences, Scottish Enterprise. "The ability of our sector leaders to collaborate and solve the many challenges facing today's life sciences industry is essential to helping companies safely and effectively deliver new therapies and products to patients."

At BIO, Scotland will feature:

  • Scotland's investment in translational medicine, with Ross McLennan of the Scottish Academic Health Sciences Collaboration (SAHSC) offering insights into how the program, launched last year by the Chief Scientist's Office, enhances Scotland's unique ability to streamline patient-oriented clinical research for pharmaceutical companies through collaboration between NHS Scotland and the nation's universities.
  • New Scottish Stem Cell Network CEO Kevin Price discussing Scotland's position as one of Europe's largest and most highly-regarded stem cell research communities and its role as home to groundbreaking regenerative medicine research such as ReNeuron's stem cell trial for stroke patients.
  • Leadership in creating a best-in-class environment for global innovation exemplified with representation of twenty-two leading Scottish life sciences organisations with support from SE/SDI.
  • Scotland as a location of choice for world-class businesses to collaborate and succeed. The Edinburgh BioQuarter, a major collaboration between Scottish Enterprise, Alexandria Real Estate Equities, Inc., University of Edinburgh and the National Health Service is an offering which exemplifies the excellence of research, clinical and commercial opportunities open to a company  locating in Scotland.  Newly appointed CEO Dr. Michael Capaldi and Chair Dr. Simon Best will discuss investments to make the BioQuarter one of the world's leading hubs for commercialization of life sciences research.

"Scotland is an exciting place to be for life sciences companies and innovators at the moment," said Allison.  "The energy, expertise and unprecedented momentum around our research and commercialisation activities are making Scotland and its collaborative approach an attractive home for cutting-edge investment."

Scotland will also present two interactive panel sessions on Monday, May 3. "From Oligos to Genes to Pathways to Genomes: DNA construction for Synthetic Biology" will cover the emerging field of synthetic biology and Scottish Enterprise's 2.4 million pounds sterling ($3.6 million) Genome Segment Assembly (GSA) research program. "Lost in Translation: Translational R&D as the Road Map to Market" will share global best practices in translational R&D.

Scottish Organizations at BIO

Aquapharm Biodiscovery Limited

Biotech Innovation & Future Health Limited

Borders Technology Management

ChimaeraBio

CXR Biosciences Ltd

GlycoMar Limited

GT Biologics Limited

Ingenza Ltd

Marks & Clerk LLP

Murgitroyd & Company

NovaBiotics Ltd

Ocutec Limited

Sistemic

Solid Form Solutions Ltd

Talent Scotland

University of Aberdeen – Research & Innovation

University of Dundee – Research & Innovation Services

University of Edinburgh – College of Medicine & Veterinary Medicine

University of Edinburgh – Edinburgh Research and Innovation

University of Edinburgh – MRC Centre for Regenerative Medicine

For more information on these companies, please visit Scottish Development International.

For further information on Scotland at BIO, please contact Emily Hyman at 617-520-7094 or ehyman@webershandwick.com.  


'/>"/>
SOURCE Scottish Enterprise; Scottish Development International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Scotland Showcased at BIO as Dynamic, Global Life Sciences Hub
2. Scotland Highlights New Partnerships and Cutting-Edge Drug Discovery Research
3. Scotland Launches Chemicals Industry Partnerships To Propel $13 Billion Sector
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... Wausau, WI (PRWEB) , ... June 23, 2016 ... ... probiotic supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, ... supplements for over 35 years, is proud to add Target to its list ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
Breaking Biology Technology:
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
(Date:3/18/2016)... , March 18, 2016 --> ... of Biometrics, ICT, Manned & Unmanned Vehicles, Physical infrastructure and ... security companies in the border security market and the continuing ... and Europe has led visiongain to ... improved success. --> defence & security companies ...
Breaking Biology News(10 mins):